Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
5
45%
Ph phase_3
1
9%
Ph phase_2
1
9%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

unknown218%
not_yet_recruiting19%
recruiting19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11